ArticleEuropean archives of psychiatry and clinical neuroscience2026
Validity of the Chinese version of the somatic symptom disorder-B criteria scale among patients with chronic cough.
Article in European archives of psychiatry and clinical neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
objectiveThis study aimed to test the validity of the Chinese Version of the Somatic Symptom Disorder-B Criteria Scale (SSD-12) for identifying Somatic Symptom Disorder (SSD) among Chinese patients with chronic cough, in accordance with Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) diagnostic criteria.
methodsParticipants completed the Chinese Version of SSD-12, a general information questionnaire, the Patient Health Questionnaire-9 (PHQ-9), the Generalized Anxiety Disorder-7 (GAD-7), the Patient Health Questionnaire-15 (PHQ-15), and the Leicester Cough Questionnaire (LCQ). The Structured Clinical Interview for DSM-5, Research Version (SCID-5-RV) served as the reference standard for SSD diagnosis, and the validity of SSD-12 was analyzed.
resultsA total of 371 patients were included. The SSD-12 demonstrated excellent internal consistency (Cronbach's α = 0.95, Spearman-Brown split-half coefficient = 0.95), with a three-factor structure explaining 78.7% of the total variance (KMO = 0.95, p < 0.001). With SCID-5-RV as the gold standard (48 SSD cases, 323 non-SSD cases), the SSD-12 exhibited excellent diagnostic accuracy (AUC = 0.969), with an optimal cut-off of 13.5 (sensitivity = 0.98, specificity = 0.94). The SSD-12 sum score was significantly correlated with PHQ-15 (r = 0.67), GAD-7 (r = 0.70), PHQ-9 (r = 0.66), and LCQ (r = -0.52, all p < 0.001), and showed significant incremental validity beyond PHQ-15 in predicting LCQ (ΔF = 45.90, p < 0.001).
conclusionsThe Chinese Version of SSD-12 demonstrates excellent reliability, validity and diagnostic performance among patients with chronic cough, thus serving as an effective and efficient tool for SSD screening in respiratory care.
trial registrationThis study was registered in the Chinese Clinical Trials Register ( http://www.chictr.org.cn/ ) (ChiCTR2400079808).
Indexed as
Identifiers
42853267What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.